OpenURL Connection Search

Select item for more details and to access through your institution.

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
Published in:
BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08298-6
By:
- van Dam, Koos P. J.;
- Volkers, Adriaan G.;
- Wieske, Luuk;
- Stalman, Eileen W.;
- Kummer, Laura Y. L.;
- van Kempen, Zoé L. E.;
- Killestein, Joep;
- Tas, Sander W.;
- Boekel, Laura;
- Wolbink, Gerrit J.;
- van der Kooi, Anneke J.;
- Raaphorst, Joost;
- Takkenberg, R. Bart;
- D'Haens, Geert R. A. M.;
- Spuls, Phyllis I.;
- Bekkenk, Marcel W.;
- Musters, Annelie H.;
- Post, Nicoline F.;
- Bosma, Angela L.;
- Hilhorst, Marc L.
Publication type:
Article
Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273.
Published in:
eLife, 2022, p. 1, doi. 10.7554/eLife.77969
By:
- Verstegen, Niels J. M.;
- Hagen, Ruth R.;
- van den Dijssel, Jet;
- Kuijper, Lisan H.;
- Kreher, Christine;
- Ashhurst, Thomas;
- Kummer, Laura Y. L.;
- Steenhuis, Maurice;
- Duurland, Mariel;
- de Jongh, Rivka;
- de Jong, Nina;
- van der Schoot, C. Ellen;
- Bos, Amélie V.;
- Mul, Erik;
- Kedzierska, Katherine;
- van Dam, Koos P. J.;
- Stalman, Eileen W.;
- Boekel, Laura;
- Wolbink, Gertjan;
- Tas, Sander W.
Publication type:
Article
Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination.
Published in:
Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.1032830
By:
- van Dam, Koos P. J.;
- Hogenboom, Laura;
- Stalman, Eileen W.;
- Kummer, Laura Y. L.;
- Steenhuis, Maurice;
- Keijser, Jim B. D.;
- ten Brinke, Anja;
- van Ham, S. Marieke;
- Kuijpers, Taco W.;
- Rispens, Theo;
- Wieske, Luuk;
- Eftimov, Filip;
- Strijbis, Eva M.;
- Killestein, Joep;
- van Kempen, Zoé L. E.
Publication type:
Article
Ocrelizumab Concentration Is a Good Predictor of SARS‐CoV‐2 Vaccination Response in Patients with Multiple Sclerosis.
Published in:
Annals of Neurology, 2023, v. 93, n. 1, p. 103, doi. 10.1002/ana.26534
By:
- van Kempen, Zoé L. E.;
- Hogenboom, Laura;
- Toorop, Alyssa A.;
- Steenhuis, Maurice;
- Stalman, Eileen W.;
- Kummer, Laura Y. L.;
- van Dam, Koos P. J.;
- Bloem, Karien;
- ten Brinke, Anja;
- van Ham, S. Marieke;
- Kuijpers, Taco W.;
- Wolbink, Gerrit J.;
- Loeff, Floris C.;
- Wieske, Luuk;
- Eftimov, Filip;
- Rispens, Theo;
- Strijbis, Eva M. M.;
- Killestein, Joep
Publication type:
Article
Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after mRNA vaccination.
Published in:
Allergy, 2024, v. 79, n. 7, p. 1952, doi. 10.1111/all.16089
By:
- Valk, Anika M.;
- Keijser, Jim B. D.;
- van Dam, Koos P. J.;
- Stalman, Eileen W.;
- Wieske, Luuk;
- Steenhuis, Maurice;
- Kummer, Laura Y. L.;
- Spuls, Phyllis I.;
- Bekkenk, Marcel W.;
- Musters, Annelie H.;
- Post, Nicoline F.;
- Bosma, Angela L.;
- Horváth, Barbara;
- Hijnen, Dirk‐Jan;
- Schreurs, Corine R. G.;
- van Kempen, Zoé L. E.;
- Killestein, Joep;
- Volkers, Adriaan G.;
- Tas, Sander W.;
- Boekel, Laura
Publication type:
Article
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases.
Published in:
2022
By:
- Wieske, Luuk;
- Kummer, Laura Y L;
- van Dam, Koos P J;
- Stalman, Eileen W;
- van der Kooi, Anneke J;
- Raaphorst, Joost;
- Löwenberg, Mark;
- Takkenberg, R Bart;
- Volkers, Adriaan G;
- D'Haens, Geert R A M;
- Tas, Sander W;
- Spuls, Phyllis I;
- Bekkenk, Marcel W;
- Musters, Annelie H;
- Post, Nicoline F;
- Bosma, Angela L;
- Hilhorst, Marc L;
- Vegting, Yosta;
- Bemelman, Frederike J;
- Killestein, Joep
Publication type:
journal article
Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1314507
By:
- Keijzer, Sofie;
- Oskam, Nienke;
- Ooijevaar-de Heer, Pleuni;
- Steenhuis, Maurice;
- Keijser, Jim B. D.;
- Wieske, Luuk;
- van Dam, Koos P. J.;
- Stalman, Eileen W.;
- Kummer, Laura Y. L.;
- Boekel, Laura;
- Kuijpers, Taco W.;
- ten Brinke, Anja;
- van Ham, S. Marieke;
- Eftimov, Filip;
- Tas, Sander W.;
- Wolbink, Gerrit J.;
- Rispens, Theo
Publication type:
Article

Found: 7

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.

Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273.

Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination.

Ocrelizumab Concentration Is a Good Predictor of SARS‐CoV‐2 Vaccination Response in Patients with Multiple Sclerosis.

Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after mRNA vaccination.

Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases.

Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection.